The widespread private equity offering at AllBright Law Offices is noted for its work on fund formation, transactions, and disputes in the private equity arena, often related to the biotech and pharmaceutical sectors. Key team members of note include Chengwei Peng, who harnesses previous experience in-house at a PE fund to advise clients, Min Xu, who handles investments and exits, and Shaojun Huang, who is well-versed in assisting venture capital and PE firms with investments across their entire lifecycles and advising on financing projects. Peng Zhou is engaged in various deals for PE firms, as well as en bloc property acquisition services. Louie Xu leads the contentious side of the practice.
Legal 500 Editorial commentary

Key clients

  • Shanghai CureGene Pharmaceutical Co., Ltd.
  • Nowwa Coffee
  • Shanghai Enoquico Biotechnology Co., Ltd.
  • Gezhi Capital
  • Zhongke Jingyi
  • CCB Financial Assets Investment Co., Ltd.
  • Agricultural Bank of China Financial Assets Investment Co., Ltd.
  • Industrial and Financial Investment (Beijing) Emerging Industry Equity Investment Fund Partnership (Limited Partnership)
  • Bank of Communications Financial Assets Investment Co., Ltd.

Other key lawyers

Chengwei Peng; Min Xu; Shaojun Huang; Peng Zhou; Louie Xu